Cancer Diagnostics Market Size, Share 2019 Industry Trends Analysis Emerging Trends, Growth Boosted By Demand and Advanced Technology till 2025

Cancer Diagnostics Market Size, Share 2019 Industry Trends Analysis Emerging Trends, Growth Boosted By Demand and Advanced Technology till 2025

Global Cancer Diagnostics Market Research Report: Information by Type (Imaging Testing, Biomarkers Testing, In Vitro Diagnostic Testing, Biopsy and others), Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma Cancer, Prostate Cancer, Liver Cancer and others), End-User (Diagnostic Centers, Hospitals and Clinics, Research Institutes and others) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) – Forecast till 2025

Competitive Dashboard:

Some of the key players profiled in the report are Armune BioScience, Inc. (U.S.), BioMark Diagnostics Inc. (Canada), Biotheranostics, Inc. (U.S.), Cancer Diagnostics, Inc. (U.S.), Arquer Diagnostics Ltd (U.K), Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), GE Healthcare (U.K), QIAGEN N.V.  (Netherlands), Thermo Fisher Scientific, Inc. (U.S.), Illumina, Inc. (Denmark), Abbott Laboratories, Inc. (U.S.), Siemens Healthcare (Germany), Philips Healthcare (U.K.), Roche Diagnostics (Switzerland), and C.R. Bard, Inc. (U.S.).


Cancer Diagnostics Market is expected to grow significantly over the forecast period. The market held a valuation of USD 122,000 million in 2018 and is projected to register a valuation of an estimated USD 163,000 Million by 2025 with 8.9% CAGR over the forecast period.

Global Cancer Diagnostics Market: Synopsis

The detailed report that has been recently published by Market Research Future (MRFR) projects that the global cancer diagnostics market is marked to exhibit noteworthy expansion at a CAGR of 11.85% during the forecast period of 2017-2023. Rise in prevalence of individuals suffering from cancer and high demand for advanced diagnostic procedures in order to receive precise and effective treatment are majorly propelling the growth of the global cancer diagnostic market. Increasing availability of diagnosis solution in the healthcare sector in the developed and developing regions and rise in government initiatives to spread awareness in the underdeveloped regions are also fueling the growth of the global cancer diagnostics market.

Market Segmentation

Market Research Future report offers an all-inclusive segmental analysis of the cancer diagnostic market on the basis of type, application and end user.

Based on type, it is segmented into tumor cancer diagnostics, imaging procedure, endoscopy based, biopsy based and others. Of these, the imaging procedure will have the largest market share over the assessment period.

Based on application, the cancer diagnostic market is segmented into pancreatic cancer, liver cancer, kidney cancer, blood cancer, skin cancer, prostate cancer, cervical cancer, colorectal cancer, breast cancer, lung cancer and others. Of these, breast cancer will have the maximum share in the market.

Based on end-user, it is segmented into research institutes, hospital, clinic, diagnostic center and others. Of these, hospital will have a robust growth over the assessment period.

Table Of Contents

Chapter 1. Executive Summary

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Overview

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers

5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants

5.1.4 Threat Of Substitutes

5.1.5 Intensity Of Rivalry

5.2 Value Chain Analysis

5.2.1 R&D And Designing

5.2.2 Manufacturing

5.2.3 Distribution & Sales

5.2.4 Post-Sales Review


Intended Audience

  • Cancer specific medical device manufacturers
  • Cancer specific medical device suppliers
  • Government Research Laboratory
  • Private Research Laboratories
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories

Browse Premium Research Report Enabled with Respective Tables and Figures @

Global Cancer Diagnostics Market: Industry Updates

In january 2019, MRM Proteomics inc. has partnered with biodesix which will allow Biodesix to utilize MRM Proteomics’s proprietary iMALDI technologies to improve the blood-based lung cancer diagnostics.

In January 2019, Veracyte, a U.S.-based genomic diagnostics comapny has partnered with Johnson & Johnson Innovation for the development and commercialization of new tests for detection of lung cancer during the early stages.

Related Trending Reports

Vocal Biomarkers Market Research Report Forecast by 2023


Neurorehabilitation Devices Market –  Report – Forecast 2022


Multiple Sclerosis Treatment Market –  Research Report – Global Forecast till 2023


About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.


Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India